in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Abbott to Expand API Manufacturing Site in Ireland
2:32 AM MST | February 15, 2012 | Deepti Ramesh
Abbott Laboratories (Chicago, IL) says it will invest €85 million ($111 million) to expand its pharmaceutical manufacturing operations at Sligo, Ireland. The manufacturing facility at Sligo manufactures active pharmaceutical ingredients (APIs) as well as finished drug products. The expansion of the facility will be completed in 2014. The expansion will provide additional space for manufacturing operations to support Abbott’s future pharmaceutical pipeline in the therapeutic areas of virology, oncology and nephrology. The investment will result in the...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee